BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 34974972)

  • 1. Efficacy and Safety of Reirradiation with Stereotactic Body Radiation Therapy for Locally Recurrent Pancreatic Adenocarcinoma.
    Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
    Clin Oncol (R Coll Radiol); 2022 Jun; 34(6):386-394. PubMed ID: 34974972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective.
    Ryan JF; Groot VP; Rosati LM; Hacker-Prietz A; Narang AK; McNutt TR; Jackson JF; Le DT; Jaffee EM; Zheng L; Laheru DA; He J; Pawlik TM; Weiss MJ; Wolfgang CL; Herman JM
    Ann Surg Oncol; 2018 Jan; 25(1):280-289. PubMed ID: 29063299
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Stereotactic body radiation therapy for the treatment of locally recurrent pancreatic cancer after surgical resection.
    Reddy AV; Hill CS; Sehgal S; He J; Zheng L; Herman JM; Meyer J; Narang AK
    J Gastrointest Oncol; 2022 Jun; 13(3):1402-1412. PubMed ID: 35837183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thoracic reirradiation with SBRT for residual/recurrent and new primary NSCLC within or immediately adjacent to a prior high-dose radiation field.
    Horne ZD; Dohopolski MJ; Clump DA; Burton SA; Heron DE
    Pract Radiat Oncol; 2018; 8(3):e117-e123. PubMed ID: 29724402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Linac-based stereotactic salvage reirradiation for intraprostatic prostate cancer recurrence: toxicity and outcomes.
    Cozzi S; Finocchi Ghersi S; Bardoscia L; Najafi M; Blandino G; Alì E; Augugliaro M; Vigo F; Ruggieri MP; Cardano R; Giaccherini L; Iori F; Botti A; Trojani V; Ciammella P; Iotti C
    Strahlenther Onkol; 2023 Jun; 199(6):554-564. PubMed ID: 36732443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stereotactic Pelvic Reirradiation for Locoregional Cancer Relapse.
    Kinj R; Doyen J; Hannoun-Lévi JM; Naghavi AO; Chand ME; Baudin G; Ferrero JM; François E; Evesque L; Borchiellini D; Benezery K; Bondiau PY
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e15-e21. PubMed ID: 32641243
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-irradiation with stereotactic body radiation therapy as a novel treatment option for isolated local recurrence of pancreatic cancer after multimodality therapy: experience from two institutions.
    Wild AT; Hiniker SM; Chang DT; Tran PT; Khashab MA; Limaye MR; Laheru DA; Le DT; Kumar R; Pai JS; Hargens B; Sharabi AB; Shin EJ; Zheng L; Pawlik TM; Wolfgang CL; Koong AC; Herman JM
    J Gastrointest Oncol; 2013 Dec; 4(4):343-51. PubMed ID: 24294505
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiation Therapy With Conventional Palliative External Beam Radiation Therapy.
    Zeng KL; Myrehaug S; Soliman H; Husain ZA; Tseng CL; Detsky J; Ruschin M; Atenafu EG; Witiw CD; Larouche J; da Costa L; Maralani PJ; Parulekar WR; Sahgal A
    Int J Radiat Oncol Biol Phys; 2022 Oct; 114(2):293-300. PubMed ID: 35675854
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interim Results of a Prospective Prostate-Specific Membrane Antigen-Directed Focal Stereotactic Reirradiation Trial for Locally Recurrent Prostate Cancer.
    Bergamin S; Eade T; Kneebone A; Booth J; Hsiao E; Schembri GP; Szymura K; Le A; Kwong C; Brown C; Hunter J; Hruby G
    Int J Radiat Oncol Biol Phys; 2020 Dec; 108(5):1172-1178. PubMed ID: 32659332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single- versus multifraction stereotactic body radiation therapy for pancreatic adenocarcinoma: outcomes and toxicity.
    Pollom EL; Alagappan M; von Eyben R; Kunz PL; Fisher GA; Ford JA; Poultsides GA; Visser BC; Norton JA; Kamaya A; Cox VL; Columbo LA; Koong AC; Chang DT
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):918-25. PubMed ID: 25585785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperfractionated abdominal reirradiation for gastrointestinal malignancies.
    Hunt A; Das P; Minsky BD; Koay EJ; Krishnan S; Herman JM; Taniguchi C; Koong A; Smith GL; Holliday EB
    Radiat Oncol; 2018 Aug; 13(1):143. PubMed ID: 30086784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reirradiation with stereotactic body radiation therapy after prior conventional fractionation radiation for locally recurrent pancreatic adenocarcinoma.
    Koong AJ; Toesca DAS; von Eyben R; Pollom EL; Chang DT
    Adv Radiat Oncol; 2017; 2(1):27-36. PubMed ID: 28740913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypofractionated Stereotactic Body Radiation Therapy With Simultaneous Integrated Boost and Simultaneous Integrated Protection in Pancreatic Ductal Adenocarcinoma.
    Simoni N; Micera R; Paiella S; Guariglia S; Zivelonghi E; Malleo G; Rossi G; Addari L; Giuliani T; Pollini T; Cavedon C; Salvia R; Milella M; Bassi C; Mazzarotto R
    Clin Oncol (R Coll Radiol); 2021 Jan; 33(1):e31-e38. PubMed ID: 32682686
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stereotactic Body Radiation Therapy for Locally Progressive and Recurrent Pancreatic Cancer after Prior Radiation.
    Sutera P; Bernard ME; Wang H; Bahary N; Burton S; Zeh H; Heron DE
    Front Oncol; 2018; 8():52. PubMed ID: 29564223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reirradiation of Locally Recurrent Prostate Cancer With Volumetric Modulated Arc Therapy.
    D'Agostino GR; Di Brina L; Mancosu P; Franzese C; Iftode C; Franceschini D; Clerici E; Tozzi A; Navarria P; Scorsetti M
    Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):614-621. PubMed ID: 30825495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stereotactic body radiotherapy (SBRT) for patients with locally advanced pancreatic cancer: A single center experience.
    Jumeau R; Delouya G; Roberge D; Donath D; Béliveau-Nadeau D; Campeau MP
    Dig Liver Dis; 2018 Apr; 50(4):396-400. PubMed ID: 29326012
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Five-Fraction Stereotactic Body Radiation Therapy (SBRT) and Chemotherapy for the Local Management of Metastatic Pancreatic Cancer.
    Lischalk JW; Burke A; Chew J; Elledge C; Gurka M; Marshall J; Pishvaian M; Collins S; Unger K
    J Gastrointest Cancer; 2018 Jun; 49(2):116-123. PubMed ID: 28044263
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Salvage prostate re-irradiation using high-dose-rate brachytherapy or focal stereotactic body radiotherapy for local recurrence after definitive radiation therapy.
    Mbeutcha A; Chauveinc L; Bondiau PY; Chand ME; Durand M; Chevallier D; Amiel J; Kee DL; Hannoun-Lévi JM
    Radiat Oncol; 2017 Mar; 12(1):49. PubMed ID: 28274241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reirradiation for isolated local recurrence of prostate cancer: Mono-institutional series of 64 patients treated with salvage stereotactic body radiotherapy (SBRT).
    Jereczek-Fossa BA; Rojas DP; Zerini D; Fodor C; Viola A; Fanetti G; Volpe S; Luraschi R; Bazani A; Rondi E; Cattani F; Vavassori A; Garibaldi C; Alessi S; Pricolo P; Petralia G; Cozzi G; De Cobelli O; Musi G; Orecchia R; Marvaso G; Ciardo D
    Br J Radiol; 2019 Feb; 92(1094):20180494. PubMed ID: 30379566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic radiotherapy for unresectable adenocarcinoma of the pancreas.
    Chang DT; Schellenberg D; Shen J; Kim J; Goodman KA; Fisher GA; Ford JM; Desser T; Quon A; Koong AC
    Cancer; 2009 Feb; 115(3):665-72. PubMed ID: 19117351
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.